Compare NAGE & NUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NAGE | NUS |
|---|---|---|
| Founded | 1999 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Other Pharmaceuticals |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 212.8M | 242.4M |
| IPO Year | 2010 | 1996 |
| Metric | NAGE | NUS |
|---|---|---|
| Price | $2.07 | $4.02 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $10.67 | N/A |
| AVG Volume (30 Days) | ★ 518.4K | 498.0K |
| Earning Date | 11-04-2026 | 11-05-2026 |
| Dividend Yield | N/A | ★ 5.99% |
| EPS Growth | 81.82 | ★ 207.80 |
| EPS | ★ 0.07 | N/A |
| Revenue | $129,423,000.00 | ★ $3,176,718,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $15.79 | $10.10 |
| P/E Ratio | $30.50 | ★ N/A |
| Revenue Growth | 29.95 | ★ 48.98 |
| 52 Week Low | $2.04 | $3.87 |
| 52 Week High | $7.12 | $11.67 |
| Indicator | NAGE | NUS |
|---|---|---|
| Relative Strength Index (RSI) | 35.09 | 37.51 |
| Support Level | $2.04 | N/A |
| Resistance Level | $3.61 | $4.99 |
| Average True Range (ATR) | 0.13 | 0.26 |
| MACD | -0.01 | -0.09 |
| Stochastic Oscillator | 5.41 | 13.67 |
Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.
Nu Skin Enterprises Inc develops and distributes a comprehensive line of beauty and wellness solutions in various countries. The company operates in two primary product categories: beauty and wellness products. Additionally, the company also operates through its subsidiary, Rhyz. It reports revenue from nine segments, consisting of its seven geographic Nu Skin segments: Americas, Southeast Asia/Pacific, Mainland China, Japan, Europe & Africa, South Korea, and Hong Kong/Taiwan and two Rhyz segments: manufacturing, which includes manufacturing and packaging subsidiaries it has acquired; and Rhyz Other, which includes other investments by its Rhyz strategic investment arm. The majority of the company's revenue is generated from the Wellness product category from the Americas segment.